Status:
RECRUITING
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
ASD
Functional Magnetic Resonance Imaging
Eligibility:
All Genders
10-20 years
Phase:
NA
Brief Summary
Most studies use static visual percepts that are less representative of joint attention versus an ecological environment. This has the consequence of decreasing the perception of an interaction with a...
Eligibility Criteria
Inclusion
- For the group of people with Autism Spectrum Disorders (experimental group):
- Age between 10 to 20 years old
- Diagnosis of ASD (CARS) ≥ 30 performed at inclusion
- IQ test evaluation (regardless of the result) performed by a trained psychologist
- Obtaining informed oral and written consent after appropriate information
- Obtaining informed oral and written consent from the legal guardian after information
- Be affiliated with social security
- No contraindication to magnetic resonance imaging
- For the TD (Typical Development) group of people (control group):
- Age between 10 to 20 years old
- Diagnosis of ASD (CARS) \<30 performed at inclusion
- IQ test evaluation (regardless of the result) performed by a trained psychologist
- Obtaining informed oral and written consent after appropriate information
- Obtaining informed oral and written consent from the legal guardian after information
- Be affiliated with social security
- No contraindication to magnetic resonance imaging
Exclusion
- For all groups:
- Age outside the range 10 to 20 years
- Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.)
- Person suffering from major obesity (\> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter \<70cm)
- Pregnant or breastfeeding woman
- Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision
- For TD people (control group):
- Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia.
- Person with a neurological history such as epilepsy and / or neurovascular accident.
Key Trial Info
Start Date :
January 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05194254
Start Date
January 4 2022
End Date
June 1 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens Picardie
Amiens, Picardie, France, 80054